Financhill
Back

Entrada Therapeutics Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
64

TRDA
Entrada Therapeutics

Last Price:
19.01
Seasonality Move:
-34.31%

7 Day Trial

ALL ACCESS PASS

$ 7

Write This Down: Tuesday at 2 p.m. ET!

Don't Miss Our LIVE Trade

Entrada Therapeutics Stock Forecast

  • Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 7.2% based on the past 3 years of stock performance.
  • Entrada Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Entrada Therapeutics Stock Undervalued?
    The current Entrada Therapeutics [TRDA] share price is $18.62. The Score for TRDA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • TRDA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Entrada Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Entrada Therapeutics has on average historically fallen by 7.2% based on the past 3 years of stock performance.

Entrada Therapeutics Stock Rating

Buy
64
Entrada Therapeutics (TRDA) is a Buy

Is Entrada Therapeutics overpriced?

  • Entrada Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Entrada Therapeutics Stock Price History

Is TRDA stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TRDA is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
entradatx.com

52-Week Data

52-Week High:
18.62
52-Week Low:
10.75

Prediction Charts

Market Cap:
692.66M
Price in USD:
18.62
Volume:
153.69K
Beta:
-0.26

Technical Analysis

SMA50:
16.25
SMA100:
15.98
SMA200:
14.96
52-Wk Change:
11.83%

Stock Predictions

  • Is Entrada Therapeutics stock public?
    Yes, Entrada Therapeutics is a publicly traded company.
  • What is the Entrada Therapeutics stock quote today?
    The Entrada Therapeutics stock price is 18.62 USD today.
  • How to buy Entrada Therapeutics stock online?
    You can buy Entrada Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 17.78 17.66 18.01 17.54
Oct-18 17.73 17.44 17.80 17.31
Oct-21 17.35 17.32 17.49 16.80
Oct-22 17.19 17.13 17.52 16.89
Oct-23 17.00 16.97 17.17 16.81
Oct-24 17.00 16.84 17.42 16.81
Oct-25 17.01 16.99 17.74 16.99
Oct-28 17.17 17.37 17.75 17.17
Oct-29 17.41 17.29 17.64 16.96
Oct-30 17.25 17.23 17.54 17.08
Oct-31 17.25 17.14 17.34 17.04
Nov-1 17.16 17.60 17.86 17.16
Nov-4 17.62 17.76 18.10 17.44
Nov-5 18.05 18.62 18.62 17.25

Entrada Therapeutics Earnings

Entrada Therapeutics Earnings Report: Per Share Entrada Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Entrada Therapeutics Forecast Revenue Growth

Entrada Therapeutics Stock Analysis: Historical quarterly revenues per share for Entrada Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.68 per share, and a decrease next year of $3.79 per share.

* Entrada Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.